Tag: VLA1553
Valneva: Positive data for VLA1553 in adolescents
Receive daily value for free every morning The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its service…
Valneva: positive data for VLA1553 in adolescents
(CercleFinance.com) – Valneva announces positive early Phase III safety data in adolescents for its single-dose chikungunya vaccine candidate, VLA1553, data from the ongoing VLA1553-321 trial in Brazil . According to…
Valneva: positive data for VLA1553 in adolescents – 08/28/2023 at 07:22
(CercleFinance.com) – Valneva announces positive early Phase III safety data in adolescents for its single-dose chikungunya vaccine candidate, VLA1553, data from the ongoing VLA1553-321 trial in Brazil . According to…